Psychemedics Shares Outstanding 2010-2024 | PMD
Psychemedics shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Psychemedics Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
6 |
| 2022 |
6 |
| 2021 |
6 |
| 2020 |
6 |
| 2019 |
6 |
| 2018 |
6 |
| 2017 |
6 |
| 2016 |
5 |
| 2015 |
5 |
| 2014 |
5 |
| 2013 |
5 |
| 2012 |
5 |
| 2011 |
5 |
| 2010 |
5 |
| 2009 |
5 |
Psychemedics Quarterly Shares Outstanding
(Millions of Shares) |
| 2024-09-30 |
6 |
| 2024-06-30 |
6 |
| 2024-03-31 |
6 |
| 2023-12-31 |
6 |
| 2023-09-30 |
6 |
| 2023-06-30 |
6 |
| 2023-03-31 |
6 |
| 2022-12-31 |
6 |
| 2022-09-30 |
6 |
| 2022-06-30 |
6 |
| 2022-03-31 |
6 |
| 2021-12-31 |
6 |
| 2021-09-30 |
6 |
| 2021-06-30 |
6 |
| 2021-03-31 |
6 |
| 2020-12-31 |
6 |
| 2020-09-30 |
6 |
| 2020-06-30 |
6 |
| 2020-03-31 |
6 |
| 2019-12-31 |
6 |
| 2019-09-30 |
6 |
| 2019-06-30 |
6 |
| 2019-03-31 |
6 |
| 2018-12-31 |
6 |
| 2018-09-30 |
6 |
| 2018-06-30 |
6 |
| 2018-03-31 |
6 |
| 2017-12-31 |
6 |
| 2017-09-30 |
6 |
| 2017-06-30 |
6 |
| 2017-03-31 |
6 |
| 2016-12-31 |
5 |
| 2016-09-30 |
6 |
| 2016-06-30 |
5 |
| 2016-03-31 |
5 |
| 2015-12-31 |
5 |
| 2015-09-30 |
5 |
| 2015-06-30 |
5 |
| 2015-03-31 |
5 |
| 2014-12-31 |
5 |
| 2014-09-30 |
5 |
| 2014-06-30 |
5 |
| 2014-03-31 |
5 |
| 2013-12-31 |
5 |
| 2013-09-30 |
5 |
| 2013-06-30 |
5 |
| 2013-03-31 |
5 |
| 2012-12-31 |
5 |
| 2012-09-30 |
5 |
| 2012-06-30 |
5 |
| 2012-03-31 |
5 |
| 2011-12-31 |
5 |
| 2011-09-30 |
5 |
| 2011-06-30 |
5 |
| 2011-03-31 |
5 |
| 2010-12-31 |
5 |
| 2010-09-30 |
5 |
| 2010-06-30 |
5 |
| 2010-03-31 |
5 |
| 2009-12-31 |
5 |
| 2009-09-30 |
5 |
| 2009-06-30 |
5 |
| 2009-03-31 |
5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.000B |
$0.022B |
|
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|
